Arvinas (ARVN) Non-Current Debt (2017 - 2026)
Arvinas (ARVN) posted quarterly Non-Current Debt of $500000.0 for Q1 2026, down 28.57% year-over-year from $700000.0 in Q1 2025, and up 25.0% quarter-over-quarter from $400000.0 in Q4 2025.
Arvinas (ARVN) Non-Current Debt (2017 - 2026) Analysis & Trends
Arvinas' Non-Current Debt history runs 10 years deep, the most recent figure standing at $500000.0 for Q1 2026.
- In Q1 2026, Non-Current Debt fell 28.57% year-over-year to $500000.0; the TTM figure through Mar 2026 stood at $500000.0 (down 28.57% YoY), while the FY2025 annual figure was $400000.0, down 50.0% from the prior year.
- Non-Current Debt for Q1 2026 stood at $500000.0, up from $400000.0 in the prior quarter.
- The five-year high for Non-Current Debt was $1.0 million in Q1 2022, with the low at $400000.0 in Q4 2025.
- The 5-year median for Non-Current Debt is $800000.0 (2023), against an average of $788235.3.
- Peak annual rise in Non-Current Debt reached 0.0% in 2022, while the deepest fall reached 50.0% in 2022.
- Arvinas' Non-Current Debt stood at $1.0 million in 2022, then slipped by 20.0% to $800000.0 in 2023, then changed by 0.0% to $800000.0 in 2024, then slumped by 50.0% to $400000.0 in 2025, then climbed by 25.0% to $500000.0 in 2026.
- Business Quant data shows ARVN's Non-Current Debt at $500000.0 in Q1 2026, $400000.0 in Q4 2025, and $600000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 882.16 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 8.96 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | Arvinas | 585.74 Mn | 17.84 Mn | - | 500,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 500,000.00 |
| Mar 31, 2026 | 500,000.00 |
| Dec 31, 2025 | 400,000.00 |
| Sep 30, 2025 | 600,000.00 |
| Jun 30, 2025 | 700,000.00 |
| Mar 31, 2025 | 700,000.00 |
| Dec 31, 2024 | 800,000.00 |
| Sep 30, 2024 | 600,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Mar 31, 2024 | 700,000.00 |
| Dec 31, 2023 | 800,000.00 |
| Sep 30, 2023 | 1.00 Mn |
| Jun 30, 2023 | 900,000.00 |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | 1.00 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Jun 30, 2022 | 1.00 Mn |
| Mar 31, 2022 | 1.00 Mn |
| Dec 31, 2021 | 1.00 Mn |
| Sep 30, 2021 | 1.00 Mn |